# Executive Summary

**Outcome.** Every synthetic dataset the organization ships is accompanied by machine-generated
**evidence of quality** — proof that it is faithful enough, useful enough, and complete enough for
its AI use case — and the validation itself becomes a **reusable asset library** instead of work
repeated for each dataset.

**The problem.** Synthetic data is only valuable if it is *faithful enough* for the AI use case,
and teams rarely have a defensible, repeatable way to prove it. Two silent failures recur: data
that looks statistically fine but trains a worse model (a utility gap), and data that omits the
rare-but-critical cohorts the model most needs (a coverage gap). Meanwhile each team re-invents
validation from scratch.

**The approach.** This solution builds a **fidelity and validation asset library**. It measures
**statistical fidelity** (distribution distances, category frequencies, correlation preservation)
and **utility** (a Train-on-Synthetic, Test-on-Real gap) against a governed, aggregate-only
Reference Profile; it checks **coverage and edge cases** against an explicit specification; and it
reports **privacy/disclosure signals** for the privacy office. These are packaged as reusable
assets — a Field Manifest, Reference Profile, metric suite, coverage spec, and a runnable
Validation Suite that emits an **Evidence Report** with objective pass/fail gates. Five Python
tools operationalize the workflow. Work follows a pilot-first **Assess → Design → Generate/Build →
Validate → Expand** model with explicit gates and rollback.

**Why it is safe.** No real PHI is written to a shared synthetic harness, twin, or AI test
environment; reference access is read-only and minimized, and the exported Reference Profile is
aggregate-only. Automation is Python. Synthetic-data and AI/model tools are referenced at the
pattern level, with version-specific behavior deferred to the vendor's documentation. Critically,
the library supplies the **technical method and evidence only** — HIPAA/HITRUST de-identification
determinations, IRB/privacy sign-off, and disclosure-risk acceptance remain with the
organization's privacy, compliance, and legal functions.

**Bottom line.** Fidelity and utility measured, coverage checked, and validation assets reused —
so AI teams can trust the synthetic data, and the organization stops paying to re-prove quality
one dataset at a time.
